Singapore Tests Pfizer Covid‑19 Vaccine on Kids—Parents, Fingers‑Crossed!
What’s Happening?
KK Women’s and Children’s Hospital (KKH) has kicked off a new study to see how little ones respond to the Pfizer Covid‑19 shot. The trial, aimed at ages 5‑11, will give scientists a sneak peek into how well the vaccine works for our younger generation.
Eligibility Tweaks
- Must be between 5 and 11 years old
- No prior Covid‑19 infection
- Ready to get vaccinated
Why It Matters
By gathering real‑world data from these kiddos, Singapore’s health officials hope to fine‑tune vaccination policies and protect children from the virus. And yes—participants will receive a reimbursement for their time.
Government Backing
Health Minister Ong Ye Kung highlighted a growing buzz among parents after the U.S. FDA cleared Pfizer’s jab for this age group. The Expert Committee will recommend an expansion to 5‑11‑year‑olds later this month.
What the Trial Will Test
- Streamlining large‑scale delivery
- Evaluating a smaller dose (roughly one‑third of the adult shot)
Supply and Storage
Singapore has secured a pediatric supply from Pfizer. The vaccine is a bit different—same mRNA, but a special buffer that keeps it chillier, making it easier to handle and draw.
How to Join
Interested families can fill out a quick screening questionnaire online to see if their kid meets the criteria. Anyone—parents, mommies, dads, or even a kindly cousin—can complete the form.
Ready to Volunteer?
Don’t wait! Join the trial, help shape Singapore’s Covid strategy, and perhaps earn a few bucks for your little champ.
